Chimeric mutational vectors
AssigneeValiGen (US), Inc.
InventorsRamesh Kumar, Richard A. Metz
Life of this patent
Estimating the term…
Loading patent…
AssigneeValiGen (US), Inc.
InventorsRamesh Kumar, Richard A. Metz
Estimating the term…
The invention is based on the discovery that recombinagenic oligonucleobases are active in prokaryotic cells that contain a strand transfer activity (RecA) and mismatch repair activity (MutS). Using this system a type of Duplex Mutational Vector termed a Heteroduplex Mutational Vector, was shown to be more active in prokaryotic cells than the types of mutational vectors heretofore tested. Further improvements in activity were obtained by replacing the tetrathymidine linker by a nuclease resistant oligonucleotide, such as tetra-2′-O-methyl-uridine, to link the two strands of the recombinagenic oligonucleobase and removing the DNA-containing intervening segment. The claims concern Duplex Mutational Vectors that contain the above improvements. In an alternative embodiment the claims concern the use of Duplex Mutational Vectors in prokaryotic cells.
A method of introducing a change in a target DNA sequence to form a different, desired sequence in a recombination/repair competent prokaryotic cell comprising:
Dependencies are inferred from the claim text.